CureApp, Inc.
Reconstructing “treatment” with software and creating a future of app-based treatment
In the medical field, in addition to pharmaceutical products and hardware medical devices, "software medical devices" are beginning to emerge as new treatment options. One such device is the medical anti-smoking app developed by CureApp, the first treatment app in Japan to be included in insurance coverage and which doctors have begun to prescribe. We will resolve societal issues with new treatment methods that utilize evolving technology.
- Establishment Date
- July 2014
- Business
- Medical app development
- CEO
- Kohta Satake, CEO
KII’s Perspective
The strength of CureApp lies in building a common platform that enables parallel development of advanced apps for anti-smoking, hypertension, NASH, etc., by turning the thoughts of doctors into algorithms
KII growth support
Financing assistance, Sales strategy planning support, Dispatch of board observers